The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL)

This publication has 20 references indexed in Scilit:

• Inflammatory Cells and Cancer
  The Journal of Experimental Medicine, 2001
• MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
  Cell, 2000
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
  Nature Cell Biology, 2000
• The Significance of Matrix Metalloproteinases during Early Stages of Tumor Progression^a
  Annals of the New York Academy of Sciences, 1998
• Molecular Characterization and Pattern of Tissue Expression of the Gene for Neutrophil Gelatinase-Associated Lipocalin from Humans
  Genomics, 1997
• Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases.
  Gut, 1996
• Studies of the release and turnover of a human neutrophil lipocalin
  Scandinavian Journal of Clinical and Laboratory Investigation, 1995
• Serum metalloproteinases and their inhibitors: markers for malignant potential
  British Journal of Cancer, 1994
• Plasma Assay of Matrix Metalloproteinases (MMPs) and MMP-Inhibitor Complexes in Cancer.
  Annals of the New York Academy of Sciences, 1994
• THE PERMEABILITY OF GLOMERULAR CAPILLARIES TO GRADED DEXTRANS
  The Journal of cell biology, 1974